Ovid Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Ovid Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Ovid Therapeutics Inc
Rating: 1.64991675
Author: Trendlyne DVM scores

about

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated ...

2.44 -0.01 (-0.41%)

495.12% Gain from 52W Low

1.1M

XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

12.7 / 100

Technically Neutral

53.3 / 100

1Yr Price target upside is 124%

9 analysts

Ovid Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ovid Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated ...

495.12% Gain from 52W Low

SWOT Analysis

Ovid Therapeutics Inc Live Price Chart

Ovid Therapeutics Inc Live Price Chart